Atlas Trials

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

Clinical trial NCT04308668 · COMPLETED

Trial details

NCT number
NCT04308668
Sponsor
University of Minnesota
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV InfectionCoronavirusCoronavirus Infections
Start date
2020-03-17
Primary completion
2020-05-20
Enrollment
1312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.